Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403
Condition: Arthritis, Rheumatoid Intervention: Drug: ofatumumab Sponsor: GlaxoSmithKline Active, not recruiting - verified August 2011